We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+4.58%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$5.36B
AUM Growth
+$854M
(+19%)
Cap. Flow
+$792M
Cap. Flow
% of AUM
14.77%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
754
New
327
Increased
121
Reduced
79
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$82.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$78.3M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$57.7M |
| 4 |
Teradyne
TER
|
+$56.1M |
| 5 |
AbbVie
ABBV
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$66.1M |
| 2 |
Zimmer Biomet
ZBH
|
+$56.1M |
| 3 |
NVIDIA
NVDA
|
+$55.8M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$54.7M |
| 5 |
eBay
EBAY
|
+$40.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.89% |
| 2 | Technology | 25.02% |
| 3 | Communication Services | 8.75% |
| 4 | Financials | 5.58% |
| 5 | Industrials | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$634B
| $173M | 3.23% |
1,052,902
+10,217
| +1% | +$1.69M |
|
2
Amphenol
APH
$188B
| $122M | 2.28% |
3,575,128
+187,350
| +6% | +$6.32M |
|
3
Texas Instruments
TXN
$255B
| $118M | 2.2% |
612,553
+266,460
| +77% | +$49.9M |
|
|
4
KLA
KLAC
$275B
| $115M | 2.15% |
3,558,780
+2,577,800
| +263% | +$82.6M |
|
|
5
Teradyne
TER
$54.8B
| $104M | 1.94% |
777,348
+438,420
| +129% | +$56.1M |
|
|
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $102M | 1.89% |
1,084,209
+627,338
| +137% | +$57.7M |
|
|
SGEN
7
DELISTED
Seagen Inc. Common Stock
SGEN
| $91.2M | 1.7% |
577,655
+526,768
| +1,035% | +$78.3M |
|
8
Electronic Arts
EA
$52.4B
| $86.5M | 1.61% |
601,530
+154,763
| +35% | +$22M |
|
9
Global Payments
GPN
$22.1B
| $79.8M | 1.49% |
425,524
+198,695
| +88% | +$40M |
|
10
Gilead Sciences
GILD
$161B
| $74.4M | 1.39% |
1,080,167
-461,726
| -30% | -$30.8M |
|
|
11
AbbVie
ABBV
$458B
| $68.8M | 1.28% |
610,530
+469,295
| +332% | +$52.9M |
|
12
Vishay Intertechnology
VSH
$5.86B
| $68.7M | 1.28% |
3,045,053
+891,834
| +41% | +$21.4M |
|
13
Booking.com
BKNG
$138B
| $63.7M | 1.19% |
727,275
+226,175
| +45% | +$21.1M |
|
14
Advanced Micro Devices
AMD
$851B
| $62.6M | 1.17% |
666,487
+70,379
| +12% | +$5.69M |
|
|
IGMS
15
DELISTED
IGM Biosciences
IGMS
| $62M | 1.16% |
745,393
+314,710
| +73% | +$23.3M |
|
16
Intuitive Surgical
ISRG
$121B
| $60.6M | 1.13% |
197,712
-27,675
| -12% | -$7.76M |
|
17
Cooper Companies
COO
$13.7B
| $59M | 1.1% |
595,436
+279,264
| +88% | +$27.4M |
|
18
Teleflex
TFX
$5.85B
| $58M | 1.08% |
144,441
+60,328
| +72% | +$24.7M |
|
19
Alphabet (Google) Class A
GOOGL
$3.91T
| $51.9M | 0.97% |
+424,740
| New | +$49.6M |
|
20
PagSeguro Digital
PAGS
$2.57B
| $50.6M | 0.94% |
904,204
+1,950
| +0.2% | +$93.8K |
|
21
Thomson Reuters
TRI
$39.4B
| $50.2M | 0.94% |
479,932
+136,232
| +40% | +$13.7M |
|
22
Micron Technology
MU
$1.04T
| $49.7M | 0.93% |
584,542
+26,578
| +5% | +$2.24M |
|
23
Arcus Biosciences
RCUS
$3.57B
| $45.7M | 0.85% |
1,663,568
+425,838
| +34% | +$12.2M |
|
24
Boston Scientific
BSX
$65.8B
| $44.9M | 0.84% |
+1,050,527
| New | +$44.2M |
|
25
Meta Platforms (Facebook)
META
$1.51T
| $43.7M | 0.81% |
125,601
-61,218
| -33% | -$19.6M |
|
Similar funds
KAS
PAM
TCIIS
Woodline Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Woodline Partners held 754 positions worth $5.36B, up 19% from $4.51B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Woodline Partners deployed $792M of net new capital in Q2 2021, opening 327 new positions and adding to 121 existing holdings. Its largest new stake was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Danaher, an estimated $66.1M trimmed.
- Woodline Partners's largest Q2 2021 buy was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
- Woodline Partners added most to KLA in Q2 2021, an estimated $82.6M increase.
- Woodline Partners's biggest Q2 2021 reduction was Danaher, cutting an estimated $66.1M.
- Woodline Partners fully exited Zimmer Biomet in Q2 2021, selling an estimated $56.1M.
- Woodline Partners's ten largest holdings make up 20% of its $5.36B portfolio in Q2 2021.
- Woodline Partners opened 327 new positions and closed 168 in Q2 2021.
- Woodline Partners's portfolio value rose 19% quarter-over-quarter to $5.36B.
Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.